Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David E Uehling

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
Bioorganic & Medicinal Chemistry Letters|August 24, 2015
Recent progress on MAP kinase pathway inhibitorsDavid E Uehling, Philip A Harris
The Journal of Biological Chemistry|August 27, 2022
G protein-coupled receptor kinase 6 (GRK6) regulates insulin processing and secretion via effects on proinsulin conversion to insulinMatthew J Varney, Wouter Steyaert, Paul J Coucke, et al.
The Journal of Biological Chemistry|September 3, 2023
G protein-receptor kinases 5/6 are the key regulators of G protein-coupled receptor 35-arrestin interactionsAmlan Ganguly, Tezz Quon, Laura Jenkins, et al.
Bioorganic & Medicinal Chemistry Letters|June 15, 2007
Synthesis and evaluation of potent and selective beta3 adrenergic receptor agonists containing heterobiaryl carboxylic acidsBarry G Shearer, Esther Y Chao, David E Uehling, et al.
Bioorganic & Medicinal Chemistry Letters|October 10, 2008
Dual EGFR/ErbB-2 inhibitors from novel pyrrolidinyl-acetylenic thieno[3,2-d]pyrimidinesRobert D Hubbard, Scott H Dickerson, Holly K Emerson, et al.
Stem Cell Reports|September 13, 2016
Identification of RSK and TTK as Modulators of Blood Vessel Morphogenesis Using an Embryonic Stem Cell-Based Vascular Differentiation AssayLamis Hammoud, Jessica R Adams, Amanda J Loch, et al.
Journal of Medicinal Chemistry|June 22, 2026
Structural Transformation of a BRAF Inhibitor into a Selective PKR InhibitorJay Yin, Smriti Srivastava, Xiaojing Tang, et al.
Bioorganic & Medicinal Chemistry Letters|February 18, 2006
Alkynyl pyrimidines as dual EGFR/ErbB2 kinase inhibitorsAlex G Waterson, Kirk L Stevens, Michael J Reno, et al.
Journal of Medicinal Chemistry|May 18, 2026
Self-Dimerization Induced Proximity Targeting Chimeras (SDIPTAC) Lead to DCAF1 Loss of Function and Inhibition of HIV ReplicationMark F Mabanglo, Smriti Srivastava, Yusuke Matsui, et al.
Journal of Medicinal Chemistry|January 25, 2002
Synthesis and evaluation of potent and selective beta(3) adrenergic receptor agonists containing acylsulfonamide, sulfonylsulfonamide, and sulfonylurea carboxylic acid isosteresDavid E Uehling, Kelly H Donaldson, David N Deaton, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Bioorganic & Medicinal Chemistry Letters|August 24, 2015
Recent progress on MAP kinase pathway inhibitorsDavid E Uehling, Philip A Harris
The Journal of Biological Chemistry|August 27, 2022
G protein-coupled receptor kinase 6 (GRK6) regulates insulin processing and secretion via effects on proinsulin conversion to insulinMatthew J Varney, Wouter Steyaert, Paul J Coucke, et al.
The Journal of Biological Chemistry|September 3, 2023
G protein-receptor kinases 5/6 are the key regulators of G protein-coupled receptor 35-arrestin interactionsAmlan Ganguly, Tezz Quon, Laura Jenkins, et al.
Bioorganic & Medicinal Chemistry Letters|June 15, 2007
Synthesis and evaluation of potent and selective beta3 adrenergic receptor agonists containing heterobiaryl carboxylic acidsBarry G Shearer, Esther Y Chao, David E Uehling, et al.
Bioorganic & Medicinal Chemistry Letters|October 10, 2008
Dual EGFR/ErbB-2 inhibitors from novel pyrrolidinyl-acetylenic thieno[3,2-d]pyrimidinesRobert D Hubbard, Scott H Dickerson, Holly K Emerson, et al.
Stem Cell Reports|September 13, 2016
Identification of RSK and TTK as Modulators of Blood Vessel Morphogenesis Using an Embryonic Stem Cell-Based Vascular Differentiation AssayLamis Hammoud, Jessica R Adams, Amanda J Loch, et al.
Journal of Medicinal Chemistry|June 22, 2026
Structural Transformation of a BRAF Inhibitor into a Selective PKR InhibitorJay Yin, Smriti Srivastava, Xiaojing Tang, et al.
Bioorganic & Medicinal Chemistry Letters|February 18, 2006
Alkynyl pyrimidines as dual EGFR/ErbB2 kinase inhibitorsAlex G Waterson, Kirk L Stevens, Michael J Reno, et al.
Journal of Medicinal Chemistry|May 18, 2026
Self-Dimerization Induced Proximity Targeting Chimeras (SDIPTAC) Lead to DCAF1 Loss of Function and Inhibition of HIV ReplicationMark F Mabanglo, Smriti Srivastava, Yusuke Matsui, et al.
Journal of Medicinal Chemistry|January 25, 2002
Synthesis and evaluation of potent and selective beta(3) adrenergic receptor agonists containing acylsulfonamide, sulfonylsulfonamide, and sulfonylurea carboxylic acid isosteresDavid E Uehling, Kelly H Donaldson, David N Deaton, et al.
Pageof 3